Category: health
Our mission is to provide health care tips empowering, evidence-based information that you can use to help yourself and your loved ones. Our health blogs help you help yourself by offering guidance and encouragement. By following our blogs you will start feeling better. We aim to provide articles that give the audience better information that can improve their lives. Our blogs cover topics such as health, fitness and their supplements. Also, it focuses on the essential things you need to know to understand the problem you’re facing, make informed decisions, and take positive steps. We deliver our readers a better online experience. Read on!
Astrazeneca: CDSCO approves AstraZeneca’s anti-liver cancer drug combination
[ad_1] British-Swedish drugmaker AstraZeneca on Thursday said it has received approval from the Indian drug regulator for its anti-liver cancer drug tremelimumab combination in India. Tremelimumab in combination with durvalumab, which has to be administered intravenously is indicated for the treatment of patients with unresectable hepatocellular carcinoma (uHCC) This approval paves way for the launch ...
apollo: Apollo Hospitals plans digital arm stake sale
[ad_1] Apollo Hospitals is planning to raise around $200 million in equity this fiscal year by selling stake in Apollo HealthCo, its omnichannel healthcare platform. The Chennai-based healthcare group is planning to sell around 5%-6% stake in Apollo HealthCo at an enterprise valuation expected to be in the range of $2.5-$3 billion, a top company ...
PharmEasy: PharmEasy fails to raise Rs 1,000 crore equity, breaches covenant on Goldman Sachs loan
[ad_1] Within a year of raising high-cost debt from Goldman Sachs, India’s largest online pharmacy platform PharmEasy has breached its loan covenant terms after failing to raise equity, people aware of the development said. As per the terms, the company was supposed to raise equity of around Rs 1,000 crore, or about $120 million, linked ...
Docetaxel: Venus Remedies gets marketing authorization from Saudi Arabia for chemotherapy drug Docetaxel
[ad_1] Pharma major Venus Remedies Ltd on Thursday said it has secured marketing authorisation from Saudi Arabia for Docetaxel — a widely used chemotherapy drug. The development comes three months after the company received good manufacturing practices (GMP) certification from the Saudi Food and Drug Authority (SFDA) for all its production facilities at its unit ...
“From crisis to recovery – technology can help mitigate mental health challenges”, says Ishan Shivanand
[ad_1] Global authority in mental health, Ishan Shivanand The revolution in digital transformation is uproaring news today. Businesses are under added pressure to leverage Artificial Intelligence and Machine Learning, adapt to low-code platforms, increase automation, and more to deliver value to their customers. But with tech giants continuing to enhance algorithms and digital systems for ...
srl: Court asks companies to avoid any action that may harm brand SRL
[ad_1] The Delhi High has asked SRL Diagnostics, SRL and Fortis Healthcare not to take “any action” that diminishes the value of brand SRL. Earlier, Ranbaxy’s former promoter Shivinder Mohan Singh had approached the court asking it to intervene and pass an order to restrain them from “abruptly duping” and “discontinuing” the trade marks. SRL ...
sri lanka: CDSCO initiates probe into eye drop linked to vision damage in Sri Lanka
[ad_1] India‘s drug regulatory authority has initiated a probe after a popular eye drop supplied by an Indian company allegedly caused severe damage to the eyesight of patients in Sri Lanka. Several patients in Sri Lanka developed complications earlier in May, allegedly after the use of ‘Prednisolone’, an eye drop administered to them following cataract ...
immunoact: Laurus Labs invests Rs 80 crore in cell & gene therapy firm ImmunoACT
[ad_1] Laurus Labs on Wednesday invested further Rs 80 crore in the Immunoadoptive Cell Therapy Private Ltd (lmmunoACT), that’s developing an affordable CAR T-cell therapy for curing specific types of blood cancers. Laurus will get an additional stake of 7.24% in ImmunoACT, as part of Series-B funding. Post the completion of the latest round of ...
AstraZeneca India appoints Bhavana Agrawal as CFO with effect from October
[ad_1] Biopharmaceutical company AstraZeneca Pharma India has announced the appointment of Bhavana Agrawal as chief finance officer (CFO) with effect from October 1, 2023, following a transition period, said a company statement issued today. She succeeds Rajesh Marwaha, who is retiring as CFO and full-time director of the company from the close of business hours ...
Cetuximab: Lupin launches biosimilar cetuximab in pact with Enzene
[ad_1] Drug maker Lupin on Tuesday said it has inked a strategic pact with Enzene Biosciences to launch biosimilar Cetuximab in India for treatment of head and neck cancer. Pune-based Enzene Biosciences, is the subsidiary of Alkem Laboratories. Cetuximab is the first biosimilar developed for the intravenous infusion and has received approval from the Drug ...